FDA Inspection 1080590 — Shandong Lukang Shelile Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shandong Lukang Shelile Pharmaceutical Co., Ltd. on December 14, 2018 in Jining. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 14, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jining (China)